Long-Term Assets: The sum of all assets classified as non-current.
Allarity Therapeutics, Inc. (ALLR) had Long-Term Assets of $0.33M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
-- |
|
$-2.81M |
|
-- |
|
-- |
|
$2.52M |
|
$-2.52M |
|
$-0.29M |
|
$-2.81M |
|
$-2.81M |
|
$-2.81M |
|
$-2.81M |
|
$-2.81M |
|
$-2.81M |
|
$-2.52M |
|
$-2.56M |
|
14.74M |
|
14.74M |
|
$-0.19 |
|
$-0.19 |
|
| Balance Sheet Financials | |
$20.47M |
|
$0.33M |
|
|
Long-Term Assets |
$0.33M |
$20.80M |
|
$8.79M |
|
-- |
|
-- |
|
$8.79M |
|
$12.01M |
|
$12.01M |
|
$12.01M |
|
16.11M |
|
| Cash Flow Statement Financials | |
$-11.58M |
|
-- |
|
$10.89M |
|
$19.53M |
|
$16.89M |
|
$-2.64M |
|
$0.54M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.33 |
|
-- |
|
-- |
|
-- |
|
0.12 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-11.58M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-23.36% |
|
-23.36% |
|
-13.49% |
|
-23.36% |
|
$0.75 |
|
$-0.79 |
|
$-0.79 |
|